Article Text

Download PDFPDF
Poisoning in adolescents in the UK: a review of enquiries to the National Poisons Information Service
  1. Annie Watt1,
  2. Thomas Caparrotta1,
  3. Sally Bradberry2,
  4. Laurence Gray3,
  5. Ruben Thanacoody4,
  6. Gill Jackson1,
  7. Euan A Sandilands1
  1. 1National Poisons Information Service, Royal Infirmary of Edinburgh, Edinburgh, Scotland, UK
  2. 2National Poisons Information Service, City Hospital, Birmingham, England, UK
  3. 3National Poisons Information Service, University Hospital Llandough, Llandough, Wales, UK
  4. 4National Poisons Information Service, Regional Drug & Therapeutics Centre, Newcastle upon Tyne, England, UK
  1. Correspondence to Annie Watt; annie.watt{at}nhs.scot

Abstract

Objective The objective of this study is to analyse enquiries received by the UK National Poisons Information Service (NPIS) regarding poisoning in adolescent patients.

Design A retrospective analysis of telephone enquiries regarding patients aged 10–18 years inclusive to the UK NPIS between 1 January 2015 and 31 December 2022. Data analysed included patient demographics, nature of the poisoning, agent(s) involved and poisoning severity.

Results A total of 29 750 enquiries were received, of which 66% were regarding female patients. The largest proportion overall involved intentional self-poisoning. These enquiries have significantly increased since 2019, particularly in patients aged 10–12 (2019: 71 (2.2%) vs 2022: 181 (4.3%); p<0.0001) and 13–15 (796 (24.3%) (2019) vs 1429 (33.9%) (2022); p<0.0001). Pharmaceutical agents were most often implicated, with paracetamol and non-steroidal anti-inflammatory drugs being most common. Enquiries involving these agents have significantly increased since 2019. Recreational drugs were only involved in 4.3% of enquiries. Most cases (87.6%) were of low toxicity, but 44 deaths were recorded during the study.

Conclusions Self-poisoning in adolescent patients is an important issue in the UK. NPIS enquiries regarding intentional self-poisoning have risen significantly since 2019 and the COVID-19 pandemic and increasingly involve younger patients aged 10–12 and 13–15 years. Easily accessible medicines are most often involved. With improved recognition and understanding of this problem, initiatives can be targeted to those most at risk.

  • Adolescent Health
  • Toxicology
  • Covid-19
  • Epidemiology
  • Mental health

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

View Full Text

Footnotes

  • Contributors AW and EAS led the analysis and oversaw the writing of the paper. TC assisted with the statistical analysis. SB, LG, HKRT and GJ oversaw data collection and contributed to the writing of the paper. AW is responsible for overall content (as guarantor).

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.